Catalent has acquired Micron Technologies, a provider of particle-size engineering technologies. Micron Technologies currently operates two facilities, respectively in Malvern, Pennsylvannia and in Dartford, the UK.

Micron employs approximately 100 people across both sites. Micron Technologies has more than 25 years of experience in air jet-milling micronization and is capable of processing R&D and commercial volumes at both of its sites. Micron Technologies currently supports active programs involving more than 300 customers. Both facilities are equipped with advanced systems to ensure the quality, safety, and total containment of highly potent and cytotoxic compounds and to provide integrated analytical services capabilities from early-stage development to commercialization.

The acquisition is Catalent's second since its initial public offering in July 2014 and follows the acquisition of Redwood Bioscience, with its SMARTag antibody-drug conjugate (ADC) technology platform, in October 2014. 

Source: Catalent